PGXL Technologies is the sister company of PGXL Laboratories, which applies the clinical application of pharmacogenetic and molecular diagnostic testing for personalized medicine. It is PGXL TechnologiesÂ’ mission to identify and commercialize new technologies to improve medical outcomes and advance the cause of personalized medicine.The company operates as both a commercial and research laboratory and is engaged with the development of personalized medicine at the level of discovery, assay development and clinical testing.PGXL conducts contract technical development for a wide variety of clients who are developing new drugs or researching new ways of applying genetics to the treatment of diseases and disorders. PGXL Tech performs rare cell recovery and NextGen Sequencing, Assay Development and Validation and contract research.